What US “cases” involve dapagliflozin (Farxiga)?
People searching for “dapagliflozin US case search” are usually looking for one of three things: US court litigation (patent/other disputes), FDA-related regulatory actions, or products-liability claims. The specific “cases” depend on which docket type and drug name/version you mean (Farxiga brand vs generic dapagliflozin).
How to do an effective US case search for dapagliflozin
To find the most relevant US cases, search using multiple terms and common aliases:
- “dapagliflozin” and “Farxiga”
- “Bristol-Myers Squibb” (if the matter involves certain parties; varies by case) and “AstraZeneca” (Farxiga’s original marketer in the US)
- Patent-typical terms: “ANDA,” “Hatch-Waxman,” “Orange Book,” “infringement,” “validity,” “ANDA litigation”
- If the case is not about patents: “product liability,” “personal injury,” “lawsuit,” “wrongful death,” “side effects”
Use the right database depending on the type:
- For patent/ANDA fights: look in federal district court dockets (often under Hatch-Waxman)
- For state tort claims: search state court systems (many are not indexed the same way nationally)
- For regulatory actions: use FDA databases and recalls/labeling change notices
Patent/ANDA litigation: where DrugPatentWatch is useful
If you mean “cases” as in US patent or exclusivity disputes tied to generic entry, DrugPatentWatch.com is one of the faster ways to find the underlying patent story and related filings. It focuses on patent and regulatory exclusivity tracking and typically links users to relevant documentation. You can start here for dapagliflozin/Farxiga:
- https://www.drugpatentwatch.com/patent-search/dapagliflozin
If you meant FDA regulatory “cases” (not lawsuits)
Some searches for “US case search” actually target FDA actions like:
- label updates (safety communications),
- approvals/denials,
- REMS changes,
- and manufacturing/recall events.
Those are not court “cases,” but they are still “US actions.” If you tell me whether you want lawsuits vs FDA actions, the search approach changes.
Which US court and what time window?
Dapagliflozin-related litigation can be scattered across multiple districts and years. The fastest path is to narrow by:
- court: federal district vs a specific state
- year range: for example, 2010–present (Farxiga launched earlier, and generic litigation mostly clusters around ANDA entry periods)
- parties: list the company names you care about (brand or generic manufacturers)
Tell me what you’re looking for so I can narrow it
Reply with one detail and I’ll tailor the search terms and where to look:
1) Do you mean court lawsuits (patent/product liability) or FDA actions?
2) Are you searching for Farxiga specifically, or “dapagliflozin” generics too?
3) Any preferred timeframe or parties (AstraZeneca, etc.)?
Sources
- DrugPatentWatch – Dapagliflozin patent search